FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Precision Dose Ranitidine Oral Solution Recall

Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case

Precision Dose Inc. · South Beloit, IL

Risk level
Class II
Reported by FDA
Mar 18, 2020
Recall ID
D-1004-2020
Check your lot numberHow we source this data

Summary

Precision Dose recalled Ranitidine Oral Solution starting Nov 13, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1004-2020 on Mar 18, 2020. Reason: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API. Status: Terminated.

Why it was recalled

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.

Product description

Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080

Lot numbers, UPCs & expiration codes

Lot number: 501290, Expiry: 11/30/19, NDC: 68094-204-61; Lot number: 501326, Expiry: 11/30/19, NDC: 68094-204-62; Lot number: 501501, Expiry: 11/30/19, NDC: 68094-204-62; Lot number: 1592, Expiry: 4/30/20, NDC: 68094-204-62; Lot number: 501679, Expiry: 4/30/20, NDC: 68094-204-61, 68094-204-62

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1004-2020
Classification
Class II
Status
Terminated
Recall initiated
Nov 13, 2019
FDA report date
Mar 18, 2020
Quantity
224,940 unit dose cups
Recall type
Voluntary: Firm initiated
Recalling firm
Precision Dose Inc.

Original FDA data

Every field from FDA enforcement report D-1004-2020, exactly as published.

Show all FDA fields
City
South Beloit
State
IL
Status
Terminated
Country
United States
Event ID
85039
Address
722 Progressive Ln
Code information
Lot number: 501290, Expiry: 11/30/19, NDC: 68094-204-61; Lot number: 501326, Expiry: 11/30/19, NDC: 68094-204-62; Lot number: 501501, Expiry: 11/30/19, NDC: 68094-204-62; Lot number: 1592, Expiry: 4/30/20, NDC: 68094-204-62; Lot number: 501679, Expiry: 4/30/20, NDC: 68094-204-61, 68094-204-62
Postal code
61080-2616
Report date
Mar 18, 2020
Product type
Drugs
Recall number
D-1004-2020
Classification
Class II
Recalling firm
Precision Dose Inc.
Product quantity
224,940 unit dose cups
Termination date
Sep 17, 2022
Reason for recall
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080
Distribution pattern
Nationwide USA
Recall initiation date
Nov 13, 2019
Initial firm notification
Letter
Center classification date
Mar 12, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1004-2020, published Mar 18, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls